ClinConnect ClinConnect Logo
Search / Trial NCT06856486

Acute Intervention with Sulforaphane-Smart®

Launched by Mª JESÚS PERIAGO · Feb 27, 2025

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Glucosinolates Isothiocyanates Sulforaphane Bioavailability

ClinConnect Summary

This clinical trial is studying a special pill called Sulforaphane-Smart®, which is made from concentrated broccoli ingredients. The aim is to understand how well our bodies absorb certain beneficial compounds found in this formula, especially in adults who are normal weight or overweight. Participants will take a single dose of Sulforaphane-Smart® after fasting, and researchers will collect samples of their blood and urine to see how these compounds are processed in the body.

To be eligible for this study, you should be between 20 and 45 years old, have a normal weight or be overweight, and not have any digestive or intestinal diseases. You also should not have taken antibiotics in the last three months, be on any medication, smoke, or follow a strict diet like vegetarian or vegan. There is no comparison group in this study, meaning all participants will receive the Sulforaphane-Smart® pill. This trial is not yet recruiting participants, but it will help us learn more about how this new formula works in healthy adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • BMI: normal weight or overweight volunteers
  • No digestive or intestinal diseases
  • Age between 20 and 45 years old
  • Not having antibiotics during the previous three months
  • Not having pharmacological treatment
  • Not being smokers
  • Not following restrictive diets (vegetarian/vegan diet) or nutritional supplement
  • Exclusion Criteria:
  • BMI: low weight and obesity
  • Age different from that required
  • Digestive or intestinal diseases
  • Having antibiotics during the previous three months
  • Having pharmacological treatments
  • Following restrictive diets (vegetarian/vegan diet) or nutritional supplement
  • Smoker
  • Menopause

About Mª Jesús Periago

Mª Jesús Periago is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With extensive experience in the field, she leads initiatives that focus on innovative therapies and evidence-based practices. Her approach emphasizes collaboration with healthcare professionals and regulatory bodies to ensure adherence to the highest ethical standards and scientific rigor. By fostering an environment of transparency and accountability, Mª Jesús Periago aims to contribute significantly to the development of safe and effective treatments for various medical conditions.

Locations

Murcia, , Spain

Patients applied

0 patients applied

Trial Officials

Rocío González Barrio

Principal Investigator

Universidad de Murcia

María Jesús Periago Castón

Principal Investigator

Universidad de Murcia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported